Advancements in Prenatal Screening Lead to Earlier Surgery for Babies with Congenital Heart Defects
A new study from Epic Research reveals that the life expectancy of cystic fibrosis (CF) patients has significantly increased over the past decade. In 2008, the average life expectancy for CF patients was 26 years, but as of 2022, it has risen to 66 years, just 12% lower than the non-CF population. The study attributes this improvement to advancements in CF treatment, including better diagnoses, therapies, and comprehensive care programs. Early diagnosis through advanced testing and new therapeutic options have contributed to the increase in life expectancy. With continued genetic advances and comprehensive care, the life expectancy for CF patients is expected to rise further.